Atossa Genetics Operating Margin 2012-2024 | ATOS

Current and historical operating margin for Atossa Genetics (ATOS) over the last 10 years. The current operating profit margin for Atossa Genetics as of September 30, 2024 is 0.00%.
Atossa Genetics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2014-12-31 $0.00B $-0.01B inf%
2014-09-30 $0.00B $-0.01B inf%
2014-06-30 $0.00B $-0.01B inf%
2014-03-31 $0.00B $-0.01B inf%
2013-12-31 $0.00B $-0.01B inf%
2013-09-30 $0.00B $-0.01B inf%
2013-06-30 $0.00B $-0.01B inf%
2013-03-31 $0.00B $-0.01B inf%
2012-12-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.145B $0.000B
Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.813B 24.50
Intuitive Surgical (ISRG) United States $194.018B 101.44
Edwards Lifesciences (EW) United States $43.628B 27.70
Alcon (ALC) Switzerland $42.291B 28.30
IQVIA Holdings (IQV) United States $36.367B 20.04
IDEXX Laboratories (IDXX) United States $35.798B 42.16
DexCom (DXCM) United States $30.830B 46.43
Waters (WAT) United States $22.743B 33.63
STERIS (STE) Ireland $21.361B 24.59
SONOVA HOLDING (SONVY) Switzerland $19.498B 0.00
Hologic (HOLX) United States $17.041B 18.40
Fresenius Medical Care AG KGaA (FMS) Germany $13.902B 14.27
Sysmex ADR (SSMXY) Japan $12.298B 38.57
Globus Medical (GMED) United States $11.262B 28.52
Penumbra (PEN) United States $9.682B 94.83
Masimo (MASI) United States $9.374B 45.36
Teleflex (TFX) United States $8.514B 13.58
Glaukos (GKOS) United States $7.737B 0.00
PROCEPT BioRobotics (PRCT) United States $4.687B 0.00
Integer Holdings (ITGR) United States $4.672B 26.48
Veracyte (VCYT) United States $3.441B 103.26
Inari Medical (NARI) United States $3.299B 0.00
LivaNova (LIVN) United Kingdom $2.830B 16.33
Nihon Kohden (NHNKY) Japan $2.541B 19.30
Tandem Diabetes Care (TNDM) United States $2.253B 0.00
TransMedics (TMDX) United States $2.205B 69.90
Elekta AB (EKTAY) Sweden $2.177B 19.57
Integra LifeSciences Holdings (IART) United States $1.870B 9.77
RxSight (RXST) United States $1.447B 0.00
Alphatec Holdings (ATEC) United States $1.376B 0.00
Artivion (AORT) United States $1.237B 81.94
OPKO Health (OPK) United States $1.099B 0.00
Pulse Biosciences (PLSE) United States $1.054B 0.00
Paragon 28 (FNA) United States $0.856B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.847B 14.41
ORTHOFIX MEDICAL INC (OFIX) United States $0.691B 0.00
Mesa Laboratories (MLAB) United States $0.691B 16.28
IRadimed (IRMD) United States $0.690B 37.28
AxoGen (AXGN) United States $0.634B 0.00
Semler Scientific (SMLR) United States $0.595B 35.04
SiBone (SIBN) United States $0.571B 0.00
Pacific Biosciences Of California (PACB) United States $0.560B 0.00
OrthoPediatrics (KIDS) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.475B 0.00
ClearPoint Neuro (CLPT) United States $0.452B 0.00
Tactile Systems Technology (TCMD) United States $0.435B 23.55
Delcath Systems (DCTH) United States $0.377B 0.00
AngioDynamics (ANGO) United States $0.373B 0.00
NeuroPace (NPCE) United States $0.326B 0.00
CVRx (CVRX) United States $0.325B 0.00
Inogen (INGN) United States $0.221B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.202B 0.00
Accuray (ARAY) United States $0.193B 0.00
Sight Sciences (SGHT) United States $0.189B 0.00
Nevro (NVRO) United States $0.158B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.90
Spectral Diagnostics (EDTXF) Canada $0.104B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
Vicarious Surgical (RBOT) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
InspireMD (NSPR) Israel $0.081B 0.00
908 Devices (MASS) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
WORK Medical Technology Group (WOK) China $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.050B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Adagio Medical Holdings (ADGM) United States $0.031B 0.00
NexGel (NXGL) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.010B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00